Logo

American Heart Association

  2
  0


Final ID: Mo2131

Relationship of Collagen Metabolism Biomarkers, Left Atrial Fibrosis and Ablation Outcome in Atrial Fibrillation

Abstract Body (Do not enter title and authors here): Introduction:
Inflammation and fibrinogenesis in the left atrium are hypothesized to play a major role in the development of atrial fibrillation (AF). We previously showed that collagen metabolism biomarkers (CMB) are significantly elevated in patients with AF compared to healthy controls.

Objective:
We sought to investigate the relationship between CMB, Left Atrial Fibrosis (LAF) and AF recurrence after ablation.

Methods:
Patients with AF undergoing ablation evaluation (N= 96) were prospectively enrolled between 2015 – 2020. Plasma samples were collected prior to ablation and analyzed for CMB using commercially available ELISA kits. Sixty-four patients underwent AF ablation and were followed for 6 months for AF recurrence. CMR was performed in 48 patients using cine and 3D high resolution, late gadolinium enhancement imaging on 3T MRI to measure LAF. Patients were classified into 2 groups dichotomized by the median LAF value.

Results:
Mean age was 60.3 ± 10.3 years, mean BMI 29.7 ± 4.9 kg/m2, mean CHA2DS2-VASc score 1.9 ± 1.4 and 27% were women. Paroxysmal AF was present in 52.5%. The median LAF score was 13.6% (IQR 9.8 – 21.7). High PINP, high CITP and low TIMP-2 were associated with high LAF score (Table 1). High CITP was also associated with recurrence of AF after ablation {4.26 ng/ml (IQR 3.22 - 4.65) vs 3.26 ng/ml (IQR1.92 - 4.25), P = 0.02}.

Conclusion:
Higher levels of PINP and CITP were significantly associated with higher LAF score in AF patients. TIMP-2 was associated with low LAF. Higher CITP was also associated with AF recurrence after ablation. Further larger studies are needed to better understand the relationship between collagen biomarkers, LA fibrosis and their clinical impact on rhythm control in AF.
  • Malas, Waddah  ( Loyola University Medical Center , Chicago , Illinois , United States )
  • Syed, Mushabbar  ( Loyola University Medical Center , Maywood , Illinois , United States )
  • Poellinger, Nicholas  ( Loyola University Medical Center , Maywood , Illinois , United States )
  • Diaz, Gabriel  ( Loyola university medical center , Maywood , Illinois , United States )
  • Ikram, Mashaal  ( Northshore Medical Center , Evanston , Illinois , United States )
  • Joyce, Cara  ( Loyola University Chicago , Maywood , Illinois , United States )
  • Hoppensteadt, Debra  ( Loyola University Medical Center , Chicago , Illinois , United States )
  • Fareed, Jawed  ( LOYOLA UNIVERSITY MEDICAL CENT , Maywood , Illinois , United States )
  • Vasaiwala, Smit  ( Loyola University Medical Center , Chicago , Illinois , United States )
  • Wilber, David  ( Loyola University Medical Center , Chicago , Illinois , United States )
  • Author Disclosures:
    Waddah Malas: DO NOT have relevant financial relationships | Mushabbar Syed: DO NOT have relevant financial relationships | Nicholas Poellinger: No Answer | Gabriel Diaz: No Answer | Mashaal Ikram: DO NOT have relevant financial relationships | Cara Joyce: DO have relevant financial relationships ; Consultant:Digital Diagnostics, LLC:Active (exists now) ; Consultant:Allurion:Past (completed) | Debra Hoppensteadt: No Answer | Jawed Fareed: DO NOT have relevant financial relationships | Smit Vasaiwala: DO NOT have relevant financial relationships | David Wilber: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Optimizing Outcomes in Atrial Fibrillation - Where Do We Go from Here?

Monday, 11/18/2024 , 01:30PM - 02:30PM

Abstract Poster Session

More abstracts on this topic:
Air Filtration-Associated Changes in Cardiometabolic Protein Markers: Exploratory Analysis within a Randomized Controlled Trial

Long Clarine, Schlamp Maria Florencia, Gordon Terry, Thorpe Lorna, Newman Jonathan, Wittkopp Sharine

A randomized controlled trial of antithrombotic therapy in ischemic stroke patients with non-valvular atrial fibrillation and atherosclerosis: The ATIS-NVAF trial

Okazaki Shuhei, Uchida Kazutaka, Asakura Koko, Omae Katsuhiro, Yamamoto Haruko, Hirano Teruyuki, Toyoda Kazunori, Iguchi Yasuyuki, Noguchi Teruo, Okada Yasushi, Kitagawa Kazuo, Tanaka Kanta, Sakai Nobuyuki, Yamagami Hiroshi, Yazawa Yukako, Doijiri Ryosuke, Koga Masatoshi, Ihara Masafumi, Yamamoto Shiro, Kamiyama Kenji, Honda Yuko

More abstracts from these authors:
Angiopoeitin-2 and Mortality in an End-Stage Renal Disease, Heart Failure Population

Robbin Vanessa, Bansal Vinod, Siddiqui Fakiha, Fareed Jawed, Syed Mushabbar

The Role of Endothelial Dysfunction and Thromboinflammatory Biomarkers in the Mediation of the Pathogenesis of Atrial Fibrillation

Fareed Jawed, Dungan Gabriel, Odeh Ameer, Hoppensteadt Debra, Siddiqui Fakiha, Syed Mushabbar

You have to be authorized to contact abstract author. Please, Login
Not Available